progestin ( medroxyprogesterone acetate , trade name depo-provera , upjohn , belgium ) in 6 body-weight-matched doses with those used in women , i.e. , 0.05 mg/mouse , given intramuscularly at 4-5-day intervals ( duration of one ovulation ) induced a marked reduction of fertility with precocious atresia of graafian follicles , minimal numbers of growing follicles and an excess of corpora lutea ;
C0065864
medroxyprogesterone acetate
C0699700
depo-provera